Vantage Investment Advisors’s Cantel Medical Corporation CMD Stock Holding History

Vantage Investment Advisors’s Portfolio CMD Stock Details CMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	$75K	Hold	812	–	–	0.02%	234
2018 Q2	$80K	Buy	812 +40	+5%	+$4.47K	0.02%	224
2018 Q1	$86K	Buy	772 +1	+0.1%	+$112	0.02%	217
2017 Q4	$79K	Hold	771	–	–	0.02%	236
2017 Q3	$73K	Buy	771 +1	+0.1%	+$79	0.02%	229
2017 Q2	$60K	Hold	770	–	–	0.02%	237
2017 Q1	$62K	Buy	770 +1	+0.1%	+$79	0.02%	224
2016 Q4	$61K	Hold	769	–	–	0.02%	223
2016 Q3	$60K	Hold	769	–	–	0.03%	226
2016 Q2	$53K	Hold	769	–	–	0.02%	253
2016 Q1	$55K	Buy	769 +1	+0.1%	+$63	0.02%	233
2015 Q4	$48K	Buy	+768	New	+$46.9K	0.02%	246

Other funds holding CMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Diker Management New York $112M AUM 59.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vantage Investment Advisors's CMD Position: Q3 2018 in Review

Vantage Investment Advisors held its Cantel Medical Corporation (CMD) position steady in Q3 2018 at 812 shares worth $75K. The position accounts for 0.02% of the portfolio, ranked #234.

Vantage Investment Advisors first reported a position in CMD in Q4 2015 and has held it in 12 quarters since. The position peaked at $86K in Q1 2018. 286 funds tracked by Wall St. Rank hold CMD as of Q3 2018.

Vantage Investment Advisors held 812 shares of Cantel Medical Corporation worth $75K as of Q3 2018.
Vantage Investment Advisors left its Cantel Medical Corporation share count unchanged in Q3 2018.
Cantel Medical Corporation made up 0.02% of Vantage Investment Advisors's portfolio in Q3 2018, its #234 holding.
Vantage Investment Advisors first reported a position in Cantel Medical Corporation in Q4 2015 and has held it in 12 quarters since.
Vantage Investment Advisors's Cantel Medical Corporation position peaked at $86K in Q1 2018.
286 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q3 2018.

Based on Vantage Investment Advisors's 13F filing for Q3 2018, filed 9 Nov 2018.